Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human |
Host species | Mouse |
Applications | WB-Ti |
Brand: | Abnova |
Reference: | MAB6472 |
Product name: | PRNP monoclonal antibody, clone EM-20 |
Product description: | Mouse monoclonal antibody raised against recombinant PRNP. |
Clone: | EM-20 |
Isotype: | IgG2a |
Gene id: | 5621 |
Gene name: | PRNP |
Gene alias: | ASCR|CD230|CJD|GSS|MGC26679|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|prion |
Gene description: | prion protein |
Immunogen: | Recombinant protein corresponding to human PRNP. |
Form: | Liquid |
Recommend dilutions: | Western Blot (0.5 ug/mL) The optimal working dilution should be determined by the end user. |
Storage buffer: | In PBS, pH 7.4 (0.09% sodium azide) |
Storage instruction: | Store at 4°C. Do not freeze. Aliquot to avoid repeated freezing and thawing. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Mouse |
Antigen species / target species: | Human |
Specificity: | This antibody recognizes human prion protein (PrP). Diglycosylated form of PrP has ~40 KDa, monoglycosylated form ~30 KDa, and nonglycosylated form ~19-21 KDa. This antibody is suitable for discrimination between normal cellular prion protein (PrPc) and its conformationally changed form (PrPSc) prionprotein. |
Reactivity: | Human |
Application image: | ![]() |
Application image note: | Western Blotting analysis of Creutzfeld-Jakob disease (CJD) negative (Lane 1, 2) and CJD positive (Lane 3, 4) human brain material using PRNP monoclonal antibody, clone EM-20 (Cat # MAB6472). CJD positive patient has proteinase K resistent prion protein. Lane 1, 4 : Samples with proteinase K treatment Lane 2, 3 : Samples without proteinase K treatment. |
Applications: | WB-Ti |
Shipping condition: | Blue Ice |
Publications: | Glycosylation modification of human prion protein provokes apoptosis in HeLa cells in vitro.Yang Y, Chen L, Pan HZ, Kou Y, Xu CM. BMB Rep. 2009 Jun 30;42(6):331-7. |